GlassScriptPhysician profile
James M Gragg
NPI 1932170701
$385.92
in general payments reported to CMS, 2019-2025
10 companies · $17.50 in 2025
The $17.50 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $95.18 · 2021: $59.12 · 2023: $132 · 2024: $81.77 · 2025: $17.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $65.72 | 2020-2021 | |
| Abbott Laboratories | $55.80 | 2023-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $48.24 | 2020-2023 | Emgality, Jardiance |
| Astrazeneca Pharmaceuticals LP | $38.09 | 2024 | Farxiga, Airsupra |
| Inari Medical, INC. | $37.20 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Exact Sciences Corporation | $31.89 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $31.61 | 2023-2024 | Repatha, Otezla |
| Pfizer INC. | $28.02 | 2020 | |
| Abbvie INC. | $27.76 | 2021 | |
| Glaxosmithkline, LLC. | $21.59 | 2023 | Arexvy, Shingrix, Bexsero |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gragg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.